Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

Details

Language :

English

ISSN :

15228517

Volume :

23

Issue :

8

Database :

Complementary Index

Journal :

Neuro-Oncology

Publication Type :

Academic Journal

Accession number :

151741937

Full Text :

https://doi.org/10.1093/neuonc/noaa115